Direct sensitizing and activating effects of interleukin 31 are restricted to a single, functionally and transcriptionally classified porcine DRG neuron subtype.

This study utilizes porcine sensory neuron cultures to demonstrate that Interleukin-31 directly sensitizes and activates a specific, transcriptionally defined subset of histamine- and capsaicin-responsive pruriceptors, thereby identifying the precise neuronal class responsible for IL-31-driven chronic pruritus and offering a translational model for future research.

The Gist

The Big Picture: Why Do We Itch?

Imagine your skin is a massive security system with thousands of tiny alarm wires (nerves) running from your skin to your brain. Usually, these wires only ring the alarm when you get a scratch, a burn, or a bug bite. But sometimes, the alarm goes off for no reason, or it gets stuck in the "ON" position. This is chronic itch (pruritus).

One of the main culprits behind this stuck alarm is a protein called IL-31. Think of IL-31 as a "hijacker" that sneaks into the security system and forces the alarms to ring, making you itch uncontrollably. Doctors have drugs (like nemolizumab) that block this hijacker, and they work incredibly fast to stop the itching. But scientists didn't fully understand how or which specific wires were being hijacked, because studying human nerves directly is very difficult and unethical.

The Solution: The "Piggy" Lab

Since we can't easily poke around in human nerves, the researchers used pigs. Why pigs? Because pig skin is surprisingly similar to human skin—both in how it feels, how it gets inflamed, and how its nerves work. It's like using a high-fidelity simulator to test a car before driving it on the real road.

The Discovery: Finding the "Special Suspect"

The researchers grew pig nerve cells in a dish and tried to figure out which ones were the "itch specialists." They used a clever two-step test:

1. The Histamine Test: They squirted histamine (the chemical that makes you itch when you get a mosquito bite) on the cells.
2. The Capsaicin Test: They squirted capsaicin (the spicy stuff in chili peppers) on the cells.

They found that the nerve cells that reacted to both were the "itch specialists." In scientific terms, they call these CAP+/His+ neurons.

• The Analogy: Imagine a bouncer at a club. Most nerves are like regular guests. But the "itch specialists" are VIPs who have a special badge. If you show them Histamine, they dance. If you show them Capsaicin, they dance. But if you show them both, they go wild. The researchers found that the IL-31 hijacker only targets this specific VIP group.

The "Silent" Alarm

Here is the most fascinating part. These "itch specialists" have a weird personality.

• If you poke them hard (mechanical pressure), they often don't react. They are "silent" to touch.
• But if you give them a slow, gentle electrical pulse (like a slow sine wave), they light up like a Christmas tree.

The researchers discovered that IL-31 only talks to these "silent" VIPs. It ignores all the other nerves that feel pain or touch. This explains why blocking IL-31 stops the itch so fast—it's turning off the specific switch that controls the itch, without messing up your ability to feel a hug or a pinch.

How IL-31 Breaks the System

The study looked at two ways IL-31 messes with these nerves:

1. Direct Activation (The Rare Spark): Sometimes, IL-31 hits the nerve and makes it fire immediately. This happened, but it was rare (only about 5% of the time).
2. The "Sensitization" Effect (The Real Problem): This is the big one. Imagine you have a doorbell that you press. Usually, if you press it twice in a row, the second press is weaker because the battery is tired (this is called tachyphylaxis).
   • Without IL-31: The nerve gets tired of the itch signal quickly.
   • With IL-31: The nerve gets "super-charged." When you press the doorbell twice, the second time is just as loud as the first. IL-31 stops the nerve from getting tired. It keeps the itch signal loud and fresh, which is why chronic itch feels so relentless.

The "Skin Flush" Proof

To prove this wasn't just happening in a petri dish, they injected IL-31 directly into pig skin.

• The Result: The skin immediately turned red and flushed (like a sunburn).
• The Meaning: This redness is caused by the nerves firing and telling blood vessels to open up. It proved that IL-31 can wake up these "silent" nerves in a living animal, causing a real physical reaction.

The Takeaway

This paper is a breakthrough because it connects the dots between genetics (what the nerve looks like on a DNA level) and function (what the nerve actually does).

• Before: We knew IL-31 caused itch, but we didn't know exactly which nerve cells were responsible.
• Now: We know it's a specific, rare type of nerve cell that is "silent" to touch but "loud" to itch chemicals.

Why does this matter?
It validates that drugs like nemolizumab are hitting the right target. It also opens the door for better treatments. If we know exactly which "VIP" nerve cells are causing the problem, we can design drugs that target only those cells, stopping the itch without causing side effects like numbness or pain loss.

In short: The researchers found the specific "bad apple" in the nerve barrel that causes chronic itch, proved that IL-31 is the rot that makes it worse, and showed that stopping IL-31 is the key to fixing the problem.

Technical Summary

1. Problem Statement

Chronic pruritus (itch) is a debilitating symptom in dermatological and systemic diseases, driven significantly by Interleukin-31 (IL-31). While blocking IL-31 signaling (e.g., with nemolizumab) yields rapid anti-pruritic effects in patients, the precise neuronal mechanisms remain incompletely understood.

• Knowledge Gap: There is a disconnect between functional classifications of sensory neurons (based on electrophysiology and response to stimuli in vivo) and transcriptional classifications (based on single-cell RNA sequencing).
• Species Limitation: Mouse models often fail to recapitulate human itch physiology (e.g., differences in TRPV1 expression and IL-31 receptor activity), and direct experimentation on human somatosensory neurons is ethically restricted.
• Objective: To identify the specific neuronal subclass responsible for IL-31-driven chronic pruritus by bridging functional and transcriptomic data in a species with high physiological similarity to humans: the domestic pig.

2. Methodology

The study employed a "back-translation" approach, mapping human functional itch markers onto a porcine transcriptomic taxonomy.

• Model System: Primary dorsal root ganglion (DRG) neuron cultures from 12 domestic pigs (Sus scrofa domesticus).
• Transcriptomic Mapping: Re-analysis of a porcine snRNA-seq dataset (GSE263532) to identify neuron clusters expressing key receptors: HRH1 (histamine), TRPV1 (capsaicin), IL31RA, OSMRβ (IL-31 receptor subunits), and JAK1.
• Functional Classification (In Vitro):
  • Chemical Stimulation: Calcium imaging (Fluo-8) was used to classify neurons into three groups based on responses to Histamine (200 µM) and Capsaicin (10 µM):
    1. CAP+/His+: Respond to both (Pruriceptors).
    2. CAP+: Respond to Capsaicin only.
    3. CAP-: Non-responders.
  • Electrical Stimulation: Neurons were subjected to:
    • Rectangular pulses: 1, 2, or 4 pulses at 100 mA to assess action potential (AP) summation and calcium transient duration (T50).
    • Sinusoidal waves: Fast (20 ms, 50 Hz) and Slow (250 ms, 4 Hz) sine waves to determine activation thresholds and frequency preference.
• IL-31 Specificity:
  • Receptor Validation: Due to low evolutionary conservation, recombinant porcine IL-31 (rpIL-31) was generated and validated using a STAT3 reporter assay in HEK293 cells expressing porcine receptors. Human IL-31 was confirmed to be inactive on porcine receptors.
  • Direct Activation: rpIL-31 (272 ng/ml) was applied to DRG cultures to measure acute calcium transients.
  • Sensitization Assays:
    • Chemical: Tachyphylaxis (desensitization) to repeated histamine stimulation was measured with and without pre-treatment with rpIL-31.
    • Electrical: Changes in electrical thresholds (sine waves) and response amplitudes were measured post-rpIL-31 treatment.
• In Vivo Validation: Intradermal injections of rpIL-31 in pig skin were monitored using Laser Speckle Contrast Imaging to measure axon-reflex erythema (vasodilation), a hallmark of mechano-insensitive C-fiber activation.

3. Key Contributions

• Functional-Transcriptional Linkage: Successfully mapped the functional phenotype of "histamine-responsive, mechano-insensitive pruriceptors" to the transcriptionally defined C-OSMR-SST neuron cluster in pigs.
• Species-Specific Reagent: Demonstrated the necessity of using species-matched IL-31 (porcine) due to a lack of cross-species activity, establishing a robust protocol for porcine IL-31 signaling studies.
• Mechanistic Insight: Identified that IL-31 does not primarily act as a direct, potent pruritogen in all neurons but rather as a potent sensitizer that prevents tachyphylaxis (desensitization) to repeated itch stimuli.

4. Key Results

A. Neuron Classification and Transcriptomics

• C-OSMR-SST Cluster: This cluster uniquely co-expressed HRH1, TRPV1, IL31RA, OSMRβ, and JAK1.
• Functional Correlation: In vitro, CAP+/His+ neurons (11.9% of total) corresponded to this cluster. They showed high histamine and capsaicin responsiveness.
• Electrophysiological Signature:
  • Calcium Transients: CAP+/His+ neurons exhibited significantly longer calcium transient durations (T50) compared to CAP+ and CAP- neurons, regardless of stimulation type (rectangular or sinusoidal).
  • Frequency Preference: CAP+/His+ neurons showed a strong preference for slow sinusoidal stimulation (lower thresholds) compared to fast sine waves, a characteristic of silent/mechano-insensitive nociceptors.

B. Direct IL-31 Effects

• Direct Activation: Acute application of rpIL-31 induced calcium transients in only ~26% of CAP+/His+ neurons (and rarely in others), indicating that while the receptor is present, direct activation is sparse.
• In Vivo Confirmation: Intradermal rpIL-31 induced immediate, dose-dependent axon-reflex erythema in pig skin, confirming that these neurons can generate APs and trigger neurogenic inflammation in vivo.

C. Sensitization Effects (The Primary Mechanism)

• Prevention of Tachyphylaxis: Under control conditions, repeated histamine stimulation caused a significant drop in response amplitude (tachyphylaxis). Pre-treatment with rpIL-31 robustly prevented this desensitization, maintaining high response amplitudes to the second histamine dose.
• Electrical Sensitization: rpIL-31 treatment significantly lowered the activation threshold for fast sine wave stimulation in CAP+/His+ neurons (making them more excitable to non-preferred stimuli), but did not significantly alter response amplitudes to high-intensity rectangular pulses.
• Specificity: These sensitizing effects were exclusive to the CAP+/His+ (C-OSMR-SST) neuron subtype.

5. Significance and Conclusion

• Mechanism of Anti-Pruritic Drugs: The study elucidates why IL-31 inhibitors (like nemolizumab) work rapidly in chronic itch patients. The mechanism is not necessarily the blockade of a constant "itch signal," but the prevention of neuronal sensitization and the restoration of normal desensitization (tachyphylaxis) to repetitive pruritogens.
• Translational Model: The pig is validated as a superior model to the mouse for studying human itch neurobiology due to the conservation of the specific C-OSMR-SST neuron class and the functional properties of skin afferents.
• Therapeutic Implications: The findings suggest that targeting the IL-31/IL-31R axis specifically in mechano-insensitive, histamine-responsive C-fibers is the key to treating chronic pruritus. It highlights the importance of neuro-immune cross-talk where IL-31 primes these specific neurons to remain hyper-reactive to other itch mediators.

In summary, the paper defines a specific neuronal "itch cluster" (C-OSMR-SST) in pigs that mirrors human pruriceptors, demonstrating that IL-31's primary role in chronic itch is the sensitization and maintenance of excitability in these specific neurons, rather than direct, high-frequency firing.